This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
See how spreadsheets can help identify budget issues with clear formulas and patterns, enabling proactive corrections and better planning.
13,070 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Zscaler executives argue that AI cannot substitute for 100% reliable inline traffic inspection, even as AI workloads ...
A sharp 20% plunge in Circle tokens sparked by yield shifts under a new Clarity Act framework. This morning minute re...
A contrarian take on the tech sell-off. Learn why durable AI and cloud trends could spark a rebound and how to positi...
March’s selling surge has left more than half industry sectors mired in correction territory, prompting fresh bets on...
A Nurix Therapeutics insider recently sold shares, drawing attention from investors. This article breaks down the mov...
Optimum (OPTU) is reshaping its strategy in 2026. This original analysis dives into the Q1 results, margins, and capi...
Could Amazon pull ahead of the broader market? This article builds a disciplined case for why Amazon might outperform...
Kim Hoffman unveils an AI-powered risk platform as she champions hoffman leadership and the idea of pushing beyond se...
A hypothetical look at what could happen if a major AI tool faced a lawsuit over encouraging dangerous behavior. This...
Digimarc's Q1 2026 results shed light on its trajectory for the year. This analysis breaks down revenue, cash flow, a...
As the first quarter of 2026 unfolds, invivyd ivvd 2026 earnings take center stage for investors watching the biotech...